Achieve Life Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ACHV and other ETFs, options, and stocks.

About ACHV

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor.

CEO

Richard Alistair Balfour Stewart

CEORichard Alistair Balfour Stewart

Employees

Employees22

Headquarters

Vancouver, British Columbia

HeadquartersVancouver, British Columbia

Founded

1991

Founded1991

Employees

Employees22

ACHV Key Statistics

Market cap

96.08M

Market cap96.08M

Price-Earnings ratio

-2.58

Price-Earnings ratio-2.58

Dividend yield

—

Dividend yield—

Average volume

174.05K

Average volume174.05K

High today

$2.96

High today$2.96

Low today

$2.77

Low today$2.77

Open price

$2.94

Open price$2.94

Volume

81.96K

Volume81.96K

52 Week high

$5.59

52 Week high$5.59

52 Week low

$2.51

52 Week low$2.51

Analyst ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

Achieve Life Sciences

Why Robinhood?

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. Show more

ACHV Key Statistics

Analyst ratings

100%

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor.